ReviewBiomedicines2022
Systematic Review on the Use of Biosimilars of Trastuzumab in HER2+ Breast Cancer.
Eleni Triantafyllidi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this paperpooled ittrialcites it
ReviewBiomedicines2022
Eleni Triantafyllidi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.